irinotecan

You have access
Lack of Relationship Between Clinical Features and KRAS Mutations in Patients with Metastatic Colorectal Cancer
ANNE PLOQUIN, FARID ZERIMECH, FABIENNE ESCANDE, ANTOINE ADENIS, CLAIRE GIRAUD, LAURENT GASNAULT, VINCENT BOURGEOIS, CHRISTOPHE DESAUW and MOHAMED HEBBAR

Anticancer Research August 2016, 36 (8) 4233-4236;
You have access
Early Experience with 70-150 μm Irinotecan Drug-eluting Beads (M1-DEBIRI) for the Treatment of Unresectable Hepatic Colorectal Metastases
OLAGUOKE AKINWANDE, CHARLES SCOGGINS and ROBERT C.G. MARTIN

Anticancer Research July 2016, 36 (7) 3413-3418;
You have access
Hepatic Arterial Infusion of Polyethylene Glycol Drug-eluting Beads for Primary and Metastatic Liver Cancer Therapy
CAMILLO ALIBERTI, RICCARDO CARANDINA, DONATELLA SARTI, LUCA MULAZZANI, VINCENZO CATALANO, ALESSANDRO FELICIOLI, PAOLO COSCHIERA and GIAMMARIA FIORENTINI

Anticancer Research July 2016, 36 (7) 3515-3521;
You have access
Multicenter Phase II Study of Nedaplatin and Irinotecan for Patients with Squamous Cell Carcinoma of the Lung: Thoracic Oncology Research Group 0910
KOUZO YAMADA, HARUHIRO SAITO, TETSURO KONDO, SHUJI MURAKAMI, NORIYUKI MASUDA, MICHIKO YAMAMOTO, SATOSHI IGAWA, KEN KATONO, YUICHI TAKIGUCHI, SHUNICHIRO IWASAWA, RYOTA KURIMOTO, HIROAKI OKAMOTO, TSUNEO SHIMOKAWA, YUKIO HOSOMI, YUSUKE TAKAGI, KAZUMA KISHI, MARI OHBA, FUMIHIRO OSHITA and KOSHIRO WATANABE

Anticancer Research December 2015, 35 (12) 6705-6711;
You have access
Synergistic Effect of SN-38 in Combination with Cetuximab on Angiogenesis and Cancer Cell Invasion
MINH HIEN PHAM, LAURE DELESTRE, AMELIE DEWITTE, NICOLE WATTEZ, FREDERIC LEPRETRE and AMELIE LANSIAUX

Anticancer Research November 2015, 35 (11) 5983-5991;
You have access
The Safety of Pegylated Liposomal Doxorubicin Plus Irinotecan in Recurrent Ovarian Cancer Patients: A Phase I Trial
DAISUKE MIYAHARA, TAEKO UEDA, TAKAHIRO KATSUDA, MIYAKO MAEHARA, SATOSHI FUKAGAWA, KOHEI MIYATA, SUNG OUK NAM, HARUHIKO KONDO and SHINGO MIYAMOTO

Anticancer Research August 2015, 35 (8) 4521-4525;
You have access
Concomitant Capecitabine with Hepatic Delivery of Drug Eluting Beads in Metastatic Colorectal Cancer
OLAGUOKE AKINWANDE, AMANDA MILLER, DAVID HAYES, RYAN O'HARA, DANA TOMALTY and ROBERT C.G. MARTIN

Anticancer Research December 2014, 34 (12) 7239-7245;
You have access
Efficacy and Safety of Irinotecan Plus S-1 (IRIS) Therapy to Treat Advanced/Recurrent Colorectal Cancer
DAIJIRO HIGASHI, YUJI EGAWA, YUKIKO HIRANO, KIMIKAZU HIRANO, TORU MIYAKE, HIROYUKI TAKAHASHI, SHUGO UWATOKO, SOSEI ABE, SATOSHI YAMAMOTO, KOJI MIKAMI, KITARO FUTAMI, TAKAFUMI MAEKAWA, RYUICHI INOUE and MOTOYASU MIYAZAKI

Anticancer Research August 2014, 34 (8) 4595-4599;
You have access
Phase I Study of Combination Therapy with Irinotecan, Leucovorin, and Bolus and Continuous-infusion 5-Fluorouracil (FOLFIRI) for Advanced Colorectal Cancer in Japanese Patients
YUSUKE SASAKI, TETSUYA HAMAGUCHI, TATSUHIRO ARAI, AYUMU GOTO, TAKASHI URA, KEI MURO, YASUHIDE YAMADA, KUNIAKI SHIRAO and YASUHIRO SHIMADA

Anticancer Research April 2014, 34 (4) 2029-2034;
You have access
Randomized Phase II Trial of S-1 plus Irinotecan Versus S-1 plus Paclitaxel as First-line Treatment for Advanced Gastric Cancer (OGSG0402)
NAOTOSHI SUGIMOTO, KAZUMASA FUJITANI, HIROSHI IMAMURA, NORIYA UEDO, SHOHEI IIJIMA, MOTOHIRO IMANO, TOSHIO SHIMOKAWA, YUKINORI KUROKAWA, HIROSHI FURUKAWA and MASAHIRO GOTO

Anticancer Research February 2014, 34 (2) 851-857;

Main menu

User menu

Search

irinotecan

Pages